Reardon, David A.
Dana-Farber Cancer Institute,
United States
2024 Rank: 27269
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1224 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27269 | 28494 |
| Total Cites | 36909 | 41200 |
| H-index | 92 | 98 |
| Hm-index | 26 | 27 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 12 | 13 |
| Number of Single+First Authored Papers | 76 | 76 |
| Total Cites to Single+First Authored Papers | 5959 | 6531 |
| Number of Single+First+Last Authored Papers | 137 | 137 |
| Total Cites to Single+First+Last Authored Papers | 9742 | 10702 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 24892 | 26464 |
| Ratio of Total Citations to Distinct Citing Papers | 1.48 | 1.56 |
| Self-Citation Percentage |
10.42%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2023 Rank: 28893
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1325 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28893 | 29903 |
| Total Cites | 32296 | 36125 |
| H-index | 85 | 93 |
| Hm-index | 25 | 26 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 12 | 13 |
| Number of Single+First Authored Papers | 75 | 75 |
| Total Cites to Single+First Authored Papers | 5435 | 5959 |
| Number of Single+First+Last Authored Papers | 135 | 135 |
| Total Cites to Single+First+Last Authored Papers | 8660 | 9527 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 21961 | 23382 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.54 |
| Self-Citation Percentage |
10.60%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2022 Rank: 32684
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1509 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32684 | 33704 |
| Total Cites | 27581 | 30928 |
| H-index | 80 | 85 |
| Hm-index | 23 | 25 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 9 | 10 |
| Number of Single+First Authored Papers | 74 | 74 |
| Total Cites to Single+First Authored Papers | 4857 | 5343 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 7448 | 8229 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 18816 | 20089 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.54 |
| Self-Citation Percentage |
10.82%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2021 Rank: 33922
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1543 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33922 | 35378 |
| Total Cites | 25521 | 28642 |
| H-index | 75 | 80 |
| Hm-index | 22 | 23 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 9 | 10 |
| Number of Single+First Authored Papers | 72 | 72 |
| Total Cites to Single+First Authored Papers | 4593 | 5056 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 6904 | 7631 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 17464 | 18643 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.54 |
| Self-Citation Percentage |
10.90%
|
|
Reardon, David A.
Dana-Farber Cancer Institute,
United States
2020 Rank: 38312
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 1797 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 38312 | 38932 |
| Total Cites | 21095 | 23815 |
| H-index | 69 | 74 |
| Hm-index | 20 | 22 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 8 | 9 |
| Number of Single+First Authored Papers | 69 | 69 |
| Total Cites to Single+First Authored Papers | 4030 | 4447 |
| Number of Single+First+Last Authored Papers | 118 | 118 |
| Total Cites to Single+First+Last Authored Papers | 5720 | 6344 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14475 | 15516 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.53 |
| Self-Citation Percentage |
11.42%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.